Tonix Pharma (TNXP) Tops Q1 EPS by 16c

Tonix Pharma (NASDAQ: TNXP) reported Q1 EPS of ($0.18), $0.16 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $2.48 million versus the consensus estimate of $3.87 million.

For earnings history and earnings-related data on Tonix Pharma (TNXP) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
• Home Depot beats estimates, reaffirms fiscal 2026 guidance